# Psychosexual Disorders and Gender Identity for NEET PG Psychiatry: Erectile Dysfunction, Paraphilias, Gender Dysphoria, MHCA 2017 Ethics

Source: https://tracknation.in/story/psychosexual-disorders-and-gender-identity-for-neet-pg-psychiatry-erectile-dysfunction-paraphilias-gender-dysphoria-mhca-2017-ethics (TrackNation — free UPSC notes with PYQs)

> NEET PG Psychiatry: psychogenic versus organic erectile dysfunction and PDE5 inhibitors, when a paraphilia becomes a disorder, gender incongruence versus gender dysphoria and affirming care, and the non-discrimination, confidentiality and consent rules of the Mental Healthcare Act 2017, with a diagram, hooks, vignette MCQs and cards.

## Start Here

🎯 **Exam priority: Moderate.** *Expect: morning erections in psychogenic ED, sex therapy, PDE5 inhibitors with nitrates and
alpha-blockers, blue vision, ED as a cardiac warning, the 6-month rule for paraphilic disorder and gender dysphoria, that gender incongruence and
cross-dressing are not disorders by themselves, affirming care, and MHCA 2017 protections.*

CBME mapping: **PS 9.1–9.2** — psychosexual disorders and the medico-legal, ethical and humanitarian principles for the LGBTQA+ community.

*Gender dysphoria, paraphilias and erectile dysfunction: when each is a disorder; gender-affirming care; ED drugs; MHCA 2017. Drawn by TrackNation.*

## Erectile Dysfunction

- Causes: vascular (commonest — atherosclerosis of cavernous arteries with smoking and diabetes), neurological, hormonal, psychological and drugs.
**Psychogenic ED** is often situational (a particular place, time or partner), linked to performance anxiety, stress or depression, and the man
has **normal nocturnal and morning erections** — usually absent in organic ED.

- Evaluate every man for hormonal, neurological and vascular disease and depression; **vasculogenic ED can be the first sign of cardiovascular
disease**.

- Treatment: **sex therapy** is the mainstay for psychogenic ED. **PDE5 inhibitors** (sildenafil, tadalafil, vardenafil,
avanafil): **never with nitrates**; wait ≥ 4 hours after an alpha-blocker; adverse effects — flushing, headache, dyspepsia, visual changes
(blue haze with sildenafil/vardenafil), rarely priapism. Next: vacuum devices, intracavernosal injections, penile prosthesis.

## Paraphilias and Gender Identity

- A **paraphilia** (atypical sexual interest) is not automatically a disorder. A **paraphilic disorder** needs intense, persistent
arousal for **≥ 6 months** plus significant distress or impairment, or harm or potential harm to others (children, non-consenting adults).
More than one often coexists.

- **Gender incongruence** (ICD-11): marked, persistent mismatch between experienced gender and assigned sex — not a disorder by itself;
cross-dressing without distress needs no treatment. **Gender dysphoria** (DSM-5-TR): distress or impairment from that mismatch — diagnose
only when significant and lasting **≥ 6 months**; it can appear as early as 2–3 years of age.

- Treatment aims to relieve distress and help the person adapt — **never to dissuade them from their identity**: psychotherapy, social
transition, gender-affirming hormones (estradiol with spironolactone; testosterone) and surgery, which is linked to better mental health. Discuss
fertility preservation first. No hormones or surgery before puberty; GnRH agonists (e.g. leuprolide) may block puberty in early adolescence.

## Ethics and the Law (Mental Healthcare Act 2017)

- Every person has a right to mental healthcare **without discrimination on the basis of gender, sex or sexual orientation**, religion,
caste or class (sections 18 and 21).

- Mental illness must **not be determined by non-conformity** with moral, social, cultural, work or political values or religious beliefs
of the community (section 3).

- People with mental illness have a right to **confidentiality** (section 23); informed consent must be free of force, undue influence,
fraud or threat and given after adequate information.

## Traps the Examiner Sets

- Morning erections present → psychogenic ED.

- PDE5 inhibitor + nitrate = contraindicated.

- Gender incongruence and cross-dressing are not disorders unless they cause distress.

- "Conversion" of identity is not treatment — affirm and support.

## Memory Hooks & Shortcuts

*Shortcuts to lock in this article's numbers and lists. Each one only re-packages facts proven above.*

- 🧠 **'Morning glory = mind problem' — preserved morning erections point to psychogenic ED** — ED

- 🧠 **'Nitrate + sildenafil = never'** — drug safety

- 🧠 **'Different isn't disorder' — paraphilia, incongruence and cross-dressing need distress or harm** — definition rule

- 🧠 **Six-month rule: paraphilic disorder and gender dysphoria** — timing

- 🧠 **MHCA: 'no Discrimination, no Diagnosis by Dissent, Discretion (confidentiality)'** — law

## Rapid-Revision Cards

- Vascular (atherosclerosis).

- Situational; morning erections normal.

- Vasculogenic ED may precede CVD.

- Sex therapy.

- Sildenafil, tadalafil, vardenafil.

- Contraindicated.

- Wait ≥ 4 h.

- Sildenafil, vardenafil.

- Vacuum, injection, prosthesis.

- ≥ 6 months + distress or harm.

- Not a disorder.

- ICD-11; not a disorder itself.

- Distress ≥ 6 months.

- No distress = no disorder.

- Adapt, never dissuade.

- Estradiol + spironolactone.

- Testosterone.

- Fertility preservation.

- GnRH agonists (leuprolide).

- No discrimination incl. sexual orientation.

- No diagnosis by non-conformity.

## Sources

*Facts in this article were checked against these documents.*

- MSD Manual Professional: Erectile Dysfunction; Overview of Paraphilias and Paraphilic Disorders; Gender Incongruence and Gender Dysphoria — Merck & Co. (MSD Manuals), reviewed 2025–26 (link)

- The Mental Healthcare Act, 2017 (Act No. 10 of 2017) — Gazette of India, Ministry of Law and Justice, 2017 (link)

- Competency Based Undergraduate Curriculum, Psychiatry (PS 9) — National Medical Commission, 2024

## Test Yourself: Practice Questions

Thirty questions in NEET PG style, most of them clinical vignettes.

## Practice Questions (NEET PG pattern)

*Original questions written in the style of the exam: +4 for a correct answer, −1 for a wrong one. Every answer
was checked against the sources listed above. NEET PG papers are not published by NBEMS, so these are not past-paper questions.*

**Q1.** A man has erectile failure only with his new partner but normal morning erections. The likely type is

- (a) vasculogenic ED

- (b) neurogenic ED

- (c) psychogenic ED

- (d) endocrine ED

**Answer: (c)** — Situational; nocturnal erections preserved.

**Q2.** The most common vascular cause of erectile dysfunction is

- (a) venous leak only

- (b) trauma

- (c) Peyronie disease

- (d) atherosclerosis of the cavernous arteries

**Answer: (d)** — Smoking, diabetes.

**Q3.** A 50-year-old smoker develops new erectile dysfunction of vascular type. An important next step is to

- (a) reassure

- (b) evaluate for undiagnosed cardiovascular disease

- (c) start sex therapy only

- (d) check prolactin only

**Answer: (b)** — ED can be the first sign.

**Q4.** The mainstay of treatment for psychogenic ED is

- (a) penile prosthesis

- (b) testosterone

- (c) sex therapy

- (d) vacuum device

**Answer: (c)** — PDE5 inhibitors may help too.

**Q5.** Sildenafil is absolutely contraindicated in a man who uses

- (a) statins

- (b) metformin

- (c) nitrates

- (d) aspirin

**Answer: (c)** — Dangerous hypotension.

**Q6.** A man on tamsulosin wants to use a PDE5 inhibitor. He should

- (a) take both together

- (b) wait at least 4 hours after the alpha-blocker and start low

- (c) use nitrates instead

- (d) stop tamsulosin permanently

**Answer: (b)** — Risk of hypotension.

**Q7.** A bluish tinge to vision after taking an ED drug is typical of

- (a) alprostadil

- (b) sildenafil or vardenafil

- (c) testosterone

- (d) tadalafil only

**Answer: (b)** — Blue haze.

**Q8.** If oral PDE5 inhibitors fail or are not tolerated, options include

- (a) SSRIs

- (b) nitrates

- (c) vacuum devices, intracavernosal injections or penile prosthesis

- (d) antipsychotics

**Answer: (c)** — Per MSD.

**Q9.** Every man with ED should be evaluated for hormonal, neurological and vascular disorders and

- (a) autism

- (b) OCD

- (c) depression

- (d) schizophrenia

**Answer: (c)** — Psychological causes.

**Q10.** An atypical sexual interest becomes a paraphilic disorder only when it is intense and persistent and

- (a) is unusual

- (b) occurs once

- (c) lasts ≥ 6 months with distress, impairment or harm to others

- (d) involves fantasy only

**Answer: (c)** — Interest alone is not a disorder.

**Q11.** Which statement about paraphilias is correct?

- (a) having a paraphilic interest is not by itself a disorder

- (b) every paraphilia is a disorder

- (c) they are always illegal

- (d) they never co-occur

**Answer: (a)** — Per MSD.

**Q12.** People with one paraphilic disorder often

- (a) have more than one

- (b) never have another

- (c) have schizophrenia

- (d) are always women

**Answer: (a)** — Per MSD.

**Q13.** Gender dysphoria is defined by

- (a) distress or impairment from a mismatch between gender identity and assigned gender

- (b) sexual orientation

- (c) cross-dressing

- (d) the identity itself

**Answer: (a)** — Distress defines it.

**Q14.** Gender dysphoria should be diagnosed only when significant distress or impairment persists for at least

- (a) 2 weeks

- (b) 6 months

- (c) 5 years

- (d) 1 month

**Answer: (b)** — Per MSD.

**Q15.** In ICD-11, a marked and persistent mismatch between experienced gender and assigned sex is called

- (a) paraphilia

- (b) transvestism

- (c) gender identity disorder

- (d) gender incongruence

**Answer: (d)** — Not in the mental disorders chapter.

**Q16.** A man occasionally cross-dresses, feels comfortable and has no distress or impairment. He

- (a) needs aversion therapy

- (b) needs hormone therapy

- (c) has gender dysphoria

- (d) has no disorder and needs no treatment

**Answer: (d)** — No distress = no disorder.

**Q17.** The aim of treatment in gender dysphoria is to

- (a) stop transition

- (b) relieve distress and help the person adapt, not dissuade them from their identity

- (c) prescribe antipsychotics

- (d) change their identity

**Answer: (b)** — Affirming care.

**Q18.** Gender-affirming hormone therapy for transwomen typically uses

- (a) oestradiol with spironolactone

- (b) testosterone

- (c) progesterone alone

- (d) finasteride alone

**Answer: (a)** — Transmen: testosterone.

**Q19.** Before gender-affirming hormones or surgery, clinicians should discuss

- (a) nothing

- (b) fertility preservation

- (c) only surgery

- (d) only cost

**Answer: (b)** — Fertility may be impaired.

**Q20.** Hormones or surgery for gender dysphoria in prepubertal children are

- (a) first line

- (b) standard care

- (c) not recommended by any guideline

- (d) required by law

**Answer: (c)** — Puberty blockers may be used in early adolescence.

**Q21.** Puberty blockers used in early adolescence are

- (a) GnRH agonists such as leuprolide

- (b) antiandrogens alone

- (c) SSRIs

- (d) corticosteroids

**Answer: (a)** — Block sex hormone production.

**Q22.** Gender-affirming surgery in people with gender dysphoria is associated with

- (a) improved mental health outcomes

- (b) psychosis

- (c) worse mental health

- (d) no change

**Answer: (a)** — Per MSD.

**Q23.** Childhood gender dysphoria can manifest as early as

- (a) 2–3 years

- (b) 10 years

- (c) adulthood only

- (d) 16 years

**Answer: (a)** — Per MSD.

**Q24.** Under the Mental Healthcare Act 2017, mental healthcare must be provided without discrimination on the basis of

- (a) nothing specified

- (b) income only

- (c) gender, sex and sexual orientation, among others

- (d) age only

**Answer: (c)** — Sections 18 and 21.

**Q25.** A family brings their son to a psychiatrist because he is gay and they want him 'treated'. Under MHCA 2017,

- (a) he must be admitted

- (b) mental illness cannot be determined by non-conformity with social or moral values

- (c) he must be given ECT

- (d) the doctor must inform the police

**Answer: (b)** — Section 3.

**Q26.** MHCA 2017 gives a person with mental illness the right to

- (a) free surgery

- (b) no information

- (c) compulsory treatment

- (d) confidentiality about their mental health and treatment

**Answer: (d)** — Section 23.

**Q27.** Under MHCA 2017, valid informed consent must be

- (a) assumed in emergencies always

- (b) verbal only

- (c) obtained from the police

- (d) given for a specific intervention without force, undue influence, fraud or threat

**Answer: (d)** — After adequate information.

**Q28.** PDE5 inhibitors can rarely cause

- (a) hyperkalaemia

- (b) seizures

- (c) hypertension crisis

- (d) priapism

**Answer: (d)** — Plus flushing, headache, dyspepsia.

**Q29.** Psychological causes of secondary ED include

- (a) atherosclerosis

- (b) spinal injury

- (c) hyperprolactinaemia

- (d) performance anxiety, stress or depression

**Answer: (d)** — Often mixed with organic causes.

**Q30.** The main gender-affirming drug for transmen is

- (a) oestradiol

- (b) leuprolide only

- (c) testosterone

- (d) spironolactone

**Answer: (c)** — Per MSD.

### Active Recall

From memory: distinguish psychogenic from organic erectile dysfunction and outline treatment and PDE5 inhibitor safety, state when a paraphilia or gender incongruence becomes a disorder, describe gender-affirming care, and list the MHCA 2017 protections.
